Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.VasoGenix Pharmaceuticals, a biopharmaceutical company, has appointed Richard Rainey, former CEO of Avax Technologies, to its board of directors.
Subscribe to our email newsletter
Mr Rainey began his career as staff account manager at Ernst & Young in Philadelphia. From 1997-2008 at Avax, Mr Rainey held several leadership positions including CEO, president, CFO and director.
Mr Rainey has a BS in accounting from Pennsylvania State University and has taken master’s-level courses in taxation from the University of Washington School of Law.
Lee Southard, CEO of VasoGenix, said: “While we are pleased with the data being generated to support our new calcitonin gene related peptide agonist analogs, Rich’s experience in drug development and finance will be a help to the company as we guide VasoGenix into the future.”